Additional file 2 of An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study

Surey, J.; Stagg, H. R.; Yates, T. A.; Lipman, M.; White, P. J.; Charlett, A.; Muñoz, L.; Gosce, L.; Rangaka, M. X.; Francis, M.; Hack, V.; Kunst, H.; Abubakar, I.

doi:10.6084/m9.figshare.13627073.v1

12879_2021_5766_MOESM2_ESM.docx (36.48 kB)

Additional file 2 of An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study

journal contribution

posted on 2021-01-23, 00:45 authored by J. Surey, H. R. Stagg, T. A. Yates, M. Lipman, P. J. White, A. Charlett, L. Muñoz, L. Gosce, M. X. Rangaka, M. Francis, V. Hack, H. Kunst, I. Abubakar

Additional file 2:. CONSORT 2010 checklist of information to include when reporting a randomised trial

Funding

National Institute for Health Research

History

Usage metrics

Keywords

Tuberculosis Latent tuberculosis treatment Randomised controlled trial Rifapentine

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2 of An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study

Funding

National Institute for Health Research

History

Usage metrics

Categories

Keywords

Licence

Exports